Pacific Medical Systems ... NEWS ...
  Thursday, September 25, 2003
USCOM opens north asia gateway with Pacific Medical Systems

  
USCOM Pty Ltd, the developer of the USCOM Ultrasonic Cardiac Output Monitor today announced the conclusion of an arrangement for Pacific Medical Systems Limited to be the logistics hub that coordinates the marketing, sales and distribution of USCOM products across North Asia.
Pacific Medical Systems will take full charge of and responsibility to act as and appoint sales and distribution agents for USCOM in China, Japan, Taiwan, Korea, Hong Kong and Macau.

Based in Hong Kong, Pacific Medical Systems is under the leadership of Mr. Jules Flach, until earlier this year a senior executive in Asia for General Electric Medical Systems.

Announcing the expansion today, the Chief Executive of USCOM, Mr. Gary Davey said: “The North Asian markets, especially China and Japan are vitally important parts of the USCOM global business model. And we are delighted to have an executive of Mr. Flach’s skill and experience representing us there. We are enormously impressed by the strategic focus and quality of the business and marketing team which Mr. Flach has put in place for Pacific Medical Systems.”

Mr. Flach said: “I am extremely excited with the opportunities presented by the USCOM product and am confident of the prospects and vast potential of this cutting-edge technology in the Asian markets.”
Pacific Medical Systems will showcase USCOM at the Combined Scientific Meeting in Anaesthesiology 2003, being held in Hong Kong from September 26 to 28.
 
 

Background - USCOM:

USCOM Pty Ltd is an Australian start-up company in the development of non-invasive medical devices. USCOM has secured worldwide patents to the use of Ultrasound for the transcutaneous monitoring of intracardiac flow. The company’s technology is protected under the international patent pending protocols and its core patent has been formally accepted in both Australia and the United States.

USCOM (Ultrasonic Cardiac Output Monitors) measures blood flow across the heart valves using Continuous Wave (CW) Doppler Ultrasound, a technique which can accurately show variations in haemodynamic patterns. The USCOM machine displays real-time data about cardiac function across multiple parameters, ranging from Heart Rate to Litres-Per-Minute.

This vital information is instantly displayed in numerical and graph form, comparing current values against previous measures and averages. Until now, cardiac monitoring has needed specialised equipment and personnel and has often required an invasive procedure.

The most widely used method of measuring cardiac output is the Swan-Ganz catheter, which involves the insertion of a probe, through the patients’ groin or neck for the measurement of flow through the heart chambers. The USCOM technology is totally non-invasive, painless and operated hands-free yet produces data which is accurate, reliable and immediate.

USCOM secured Australian regulatory clearance in December 2001, with the issue of a Listing with TGA (Therapeutic Goods Administration). USCOM is a privately held Australian company, which attracted investment from the Bell Potter Medical Innovation Trust in November 2002, injecting $1.65 million for 11% of the equity of the company.

The remainder of the equity is owned by the founders of the company. USCOM is a member of the Australian Made Campaign and the Australian Technology Showcase and in 2001 was presented by the Federal Department of Science and Industry an Award for Innovation.

For further information:

  
   
 
© 2003 Pacific Medical Systems Limited. All rights reserved.